Best practices in RF ablation yield excellent outcomes for atrial fibrillation patients

FHS
May 20, 2024
10:56 am

Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S. alone.

J&J social media program aims to add more diverse voices in lung cancer advocacy

J&J is inviting underrepresented people in the lung cancer community to become digital advocates through its “BeLUNG Here” initiative. Lung cancer patients and caregivers can

February 22, 2024

Colorado lawmakers revise effort to exempt rare disease drugs from state cost caps

In response to controversy, a group of Colorado lawmakers is abandoning a bill that would have required a new state board — which is chartered

April 12, 2024

Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Agreement/Product Launch 30-Aug-2023 / 22:20 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The

August 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.